Achieve Life Sciences, Inc. Share Price
NASDAQ: ACHVAchieve Life Sciences, Inc. Stock Performance
Achieve Life Sciences, Inc. Share Price Today
As of 9 October 2026, Achieve Life Sciences, Inc.'s share price is $7.18. The stock opened at $7.13, compared to its previous close of $7.25. During today's trading session, Achieve Life Sciences, Inc.'s share price traded between $7.06 and $7.32, with an average price of $7.19. Over the past 52 weeks, the stock has recorded a high of $8.61 and a low of $2.63. In terms of performance, Achieve Life Sciences, Inc.'s share price has risen by 63.93% over the last six months and is up 39.96% on a year-on-year basis.
Achieve Life Sciences, Inc. Share Price Chart
Achieve Life Sciences, Inc. Quarterly Profit & Loss
All figures in USD
Achieve Life Sciences, Inc. Annual Profit & Loss
All figures in USD
About Achieve Life Sciences, Inc.
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
Achieve Life Sciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $7.97 | $7.20 | -11.06% |
Sep 2026 | $7.92 | $8.09 | -1.04% |
Aug 2026 | $6.30 | $8.18 | +27.73% |
Jul 2026 | $6.60 | $6.40 | -2.14% |
Jun 2026 | $5.14 | $6.54 | +24.57% |
May 2026 | $4.28 | $5.25 | +19.86% |
Apr 2026 | $3.00 | $4.38 | +48.98% |
Mar 2026 | $4.55 | $2.94 | -35.60% |
Feb 2026 | $4.14 | $4.57 | +9.47% |
Jan 2026 | $4.83 | $4.17 | -16.27% |
Dec 2025 | $4.76 | $4.98 | +1.84% |
Nov 2025 | $5.19 | $4.89 | -4.68% |